Access ESMO scientific and educational resources on Lymphomas
Recent medwireNews and resources from conferences are for ESMO Members only.
Lymphomas
Lymphomas
Clinical Practice Guidelines
Latest ESMO videos
Featured medwireNews
Zanubrutinib ‘Superior’ To Ibrutinib For Relapsed, Refractory CLL and SLL
TRIANGLE Points To Ibrutinib Benefits For Younger Mantle Cell Lymphoma Patients
Mosunetuzumab offers high response rates in relapsed or refractory follicular lymphoma
Liso-Cel CAR T-Cell Therapy May TRANSFORM Second-Line LBCL Care
Tisagenlecleucel Fails To Extend Aggressive B-Cell Lymphoma Survival
Meeting resources
Improving outcomes of cellular therapy in non-Hodgkin's B-cell lymphoma
Presenter: Monalisa Ghosh
Session: Haematological malignancies
Resources:
Slides
Webcast
Oncolytic virus therapy: A novel immunotherapeutic approach in haematologic malignancies
Presenter: Kah-Whye Peng
Session: Haematological malignancies
Resources:
Slides
Webcast
207MO - Efficacy and safety of IMC-001, anti-PD-L1 antibody, in patients with relapsed or refractory extranodal NK/T cell lymphoma, nasal type (R/R ENKTL)
Presenter: Won Seog Kim
Session: Mini Oral session: Haematological malignancies
Resources:
Abstract
Slides
Webcast
206MO - Treatment patterns in patients with mantle cell lymphoma: Report of the Asia-Pacific multinational retrospective registry study
Presenter: Hyungwoo Cho
Session: Mini Oral session: Haematological malignancies
Resources:
Abstract
Slides
Webcast
208MO - Immune related adverse events and biomarkers after Anbal-cel, novel anti-CD19 CAR-T therapy with dual silencing of PD-1 and TIGIT: Updates from phase I study
Presenter: Won Seog Kim
Session: Mini Oral session: Haematological malignancies
Resources:
Abstract
Slides
Webcast